Nates, Joseph L.
Pène, Frédéric
Darmon, Michael
Mokart, Djamel
Castro, Pedro
David, Sascha
Povoa, Pedro
Russell, Lene
Nielsen, Nathan D.
Gorecki, Gabriel-Petre
Gradel, Kim O.
Azoulay, Elie
Bauer, Philippe R.
,
Funding for this research was provided by:
Mayo Clinic, Division of Pulmonary and Critical Care
Article History
Received: 29 June 2024
Accepted: 20 August 2024
First Online: 30 August 2024
Declarations
:
: Not applicable.
: Not applicable.
: FP received lecture and consulting fees from Gilead. PC received honoraria for scientific collaboration from Pfizer, MSD, Gilead, and AbbVie, and advisory board fees from Alexion, Janssen, Sanofi and Gilead. PP received lecture fees from Gilead, Pfizer, Mundipharma, MSD and advisory board fees from Biocodex, Gilead. SD received lecture fees from Octapharm, OrphaSwiss, Alexion and advisory board fees from Alexion, Santersus, and Pantherna. The other authors declare no conflict of interest applicable to this work.